Table 4

 Prevalence of a determinant mutants in children less than 15 years who were immunised with plasma derived vaccine or recombinant vaccine in 1989, 1994, and 1999

Type of vaccineNo of children immunisedNo of immunised children infected with HBsAg positive mutantsNo of immunised children infected with HBsAg negative mutants
HBsAg, hepatitis B surface antigen.
*p = 0.122 by Poisson distribution.
Plasma derived vaccine
    198935630
    1994117551
    199996820
    Total2399*10*1
Recombinant vaccine
    1989000
    199411402
    199938901
    Total503*0*3